Senior insider sale
EVP, CLO and Secretary at ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$398.9K
1.76K shares
What this filing means
SUPRAN BRYAN plans to sell 1.76K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $398.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2026ACC: 0001959173-26-007216
Officer· EVP, CLO and Secretary
Since Mar 2026
1.76K
Shares to sell
$398.9K
Approx. market value
1.76K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
10/1/2026
1.76KTotal acquired1.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Restricted Stock Vesting Compensation | 1.76K | — |
| Total | 1.76K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.76K
Market value
$398.9K
10/2/2026
Total
Units
1.76K
Value
$398.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/2/2026 | 1.76K | $398.9K | NASDAQ | Planned |
| Total | 1.76K | $398.9K | ||